<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01476488</url>
  </required_header>
  <id_info>
    <org_study_id>Adva01SNUH</org_study_id>
    <nct_id>NCT01476488</nct_id>
  </id_info>
  <brief_title>Conversion of Prograf to Advagraf in Pediatric Renal Transplant Recipients</brief_title>
  <official_title>Conversion of Twice-a-day Tacrolimus to Once-Daily Tacrolimus Extended-Release Formulation in Stable Pediatric Kidney Transplant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was designed to compare the pharmacokinetics of Prograf and Advagraf in stable
      pediatric kidney transplant recipients.

      Enrolled patients on prograf will have pharmacokinetic study of tacrolimus for 24 hours and
      after that, the same dose of advagraf will be prescribed. The patients will have another
      pharmacokinetic study of tacrolimus after conversion to advagraf.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area Under the Curve of tacrolimus pharmacokinetics (AUC0-24)</measure>
    <description>The investigator will compare the changes in AUC0-24 of tacrolimus, Cmax, Tmax and correlation between C0 and Cmax</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Adverse Event</measure>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <condition>Kidney Transplantation</condition>
  <condition>Pediatric Patients</condition>
  <condition>Maintenance With Tacrolimus</condition>
  <arm_group>
    <arm_group_label>Advagraf</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>single group, conversion of prograf to advagraf</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tacrolimus</intervention_name>
    <arm_group_label>Advagraf</arm_group_label>
    <other_name>Prograf</other_name>
    <other_name>Advagraf</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ABO-compatible kidney-only transplantation

          -  more than 1 year after kidney transplantation

          -  5 to 15 years old

          -  patients maintained on Prograf

          -  tacrolimus level of determined previously: 4 to 20 ng/ml

          -  eGFR by Schwartz equation &gt; 50mL/min

        Exclusion Criteria:

          -  patients with acute rejection within 90 days

          -  patients with acute rejection requiring antibody therapy within 6 months

          -  patients with more than 2 times of acute rejection within 1 year

          -  AST/ALT 2 times more than upper normal limit

          -  ABO-incompatible or crossmatch-positive transplantation

          -  multiorgan transplantation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jongwon Ha, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 22, 2011</study_first_submitted>
  <study_first_submitted_qc>November 17, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 22, 2011</study_first_posted>
  <last_update_submitted>May 24, 2015</last_update_submitted>
  <last_update_submitted_qc>May 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jongwon Ha</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tacrolimus</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

